Found: 36
Select item for more details and to access through your institution.
Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 1, doi. 10.1007/s10549-014-3211-4
- By:
- Publication type:
- Article
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 223, doi. 10.1007/s10549-014-3218-x
- By:
- Publication type:
- Article
Inherited predisposition to breast cancer among African American women.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 31, doi. 10.1007/s10549-014-3195-0
- By:
- Publication type:
- Article
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 69, doi. 10.1007/s10549-014-3201-6
- By:
- Publication type:
- Article
Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 181, doi. 10.1007/s10549-014-3203-4
- By:
- Publication type:
- Article
Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 237, doi. 10.1007/s10549-014-3208-z
- By:
- Publication type:
- Article
Erratum to: Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 141, doi. 10.1007/s10549-014-3217-y
- By:
- Publication type:
- Article
Expression profiling of circulating tumor cells in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 121, doi. 10.1007/s10549-014-3215-0
- By:
- Publication type:
- Article
Stearidonic acid-enriched flax oil reduces the growth of human breast cancer in vitro and in vivo.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 17, doi. 10.1007/s10549-014-3212-3
- By:
- Publication type:
- Article
Incidence of breast cancer in a cohort of 5,135 transgender veterans.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 191, doi. 10.1007/s10549-014-3213-2
- By:
- Publication type:
- Article
Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 109, doi. 10.1007/s10549-014-3216-z
- By:
- Publication type:
- Article
Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 91, doi. 10.1007/s10549-014-3227-9
- By:
- Publication type:
- Article
Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 211, doi. 10.1007/s10549-014-3226-x
- By:
- Publication type:
- Article
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 255, doi. 10.1007/s10549-014-3219-9
- By:
- Publication type:
- Article
Geographic access and age-related variation in chemotherapy use in elderly with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 199, doi. 10.1007/s10549-014-3220-3
- By:
- Publication type:
- Article
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 163, doi. 10.1007/s10549-014-3221-2
- By:
- Publication type:
- Article
A genetic variant at 12p11 significantly modifies breast cancer risk in a genetically homogenous island population.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 41, doi. 10.1007/s10549-014-3222-1
- By:
- Publication type:
- Article
Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 49, doi. 10.1007/s10549-014-3223-0
- By:
- Publication type:
- Article
Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 133, doi. 10.1007/s10549-014-3224-z
- By:
- Publication type:
- Article
Reduced risk of axillary lymphatic spread in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 229, doi. 10.1007/s10549-014-3225-y
- By:
- Publication type:
- Article
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 59, doi. 10.1007/s10549-014-3228-8
- By:
- Publication type:
- Article
No effect of scalp cooling on survival among women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 263, doi. 10.1007/s10549-014-3231-0
- By:
- Publication type:
- Article
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 293, doi. 10.1007/s10549-014-3235-9
- By:
- Publication type:
- Article
HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 81, doi. 10.1007/s10549-014-3233-y
- By:
- Publication type:
- Article
Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 245, doi. 10.1007/s10549-014-3232-z
- By:
- Publication type:
- Article
Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 277, doi. 10.1007/s10549-014-3237-7
- By:
- Publication type:
- Article
In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 99, doi. 10.1007/s10549-014-3236-8
- By:
- Publication type:
- Article
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 285, doi. 10.1007/s10549-014-3243-9
- By:
- Publication type:
- Article
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 171, doi. 10.1007/s10549-014-3238-6
- By:
- Publication type:
- Article
Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Fulvestrant and male breast cancer: a pooled analysis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 269, doi. 10.1007/s10549-014-3240-z
- By:
- Publication type:
- Article
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 151, doi. 10.1007/s10549-014-3248-4
- By:
- Publication type:
- Article
Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies.
- Published in:
- 2015
- By:
- Publication type:
- Report
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 5, doi. 10.1007/s10549-014-3250-x
- By:
- Publication type:
- Article
Acknowledgement of reviewers 2014.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 315, doi. 10.1007/s10549-014-3261-7
- Publication type:
- Article